* Fda approves lixisenatide as adlyxintm for treatment of
adults with type 2 diabetes in u.s.
The post BRIEF-Fda approves Lixisenatide as Adlyxintm for treatment of adults with type 2 diabetes in U.S. appeared first on NASDAQ.
BRIEF-Fda approves Lixisenatide as Adlyxintm for treatment of adults with type 2 diabetes in U.S.
